圓祥生技logo

News

09.04 2023

Antibodies for T-Cell Activation (T-cube Bispecific Antibody Platform) has received a U.S. patent.

Antibodies For T-Cell Activation' has been granted a U.S. invention patent, Certificate No. 11,725,058.

關閉

建議您使用以下瀏覽器觀看本網站,
以獲得最佳瀏覽效果。

要下載瀏覽器,請直接點擊以下: